Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138

Dazhi Yu1, Fengmei An2, Xu He2

  • 1Department of Orthopedic and Traumatic Surgery, General Hospital of Jinan Military CommandJinan, Shandong, China; Department of Hand Surgery, 401 Hospital of PLAQingdao, Shandong, China.

Abstract

Insights

Curcumin treatment increases hsa-miR-138 expression in osteosarcoma cells, inhibiting proliferation and invasion by targeting Smad4, NFκB p65, and cyclin D3.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma is a primary bone malignancy with limited treatment options.
  • Curcumin, a compound from turmeric, exhibits potential anti-cancer properties.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.

Purpose of the Study:

  • To investigate the effects of curcumin on human osteosarcoma cell line MG-63.
  • To identify differentially expressed miRNAs in MG-63 cells following curcumin treatment.
  • To elucidate the mechanism of curcumin's action on MG-63 cells.

Main Methods:

  • miRNA expression profiling using Affymetrix miRNA chips.
  • Bioinformatic analysis to predict miRNA targets.
  • Validation of target gene expression (Smad4, NFκB p65, cyclin D3) via quantitative methods.
  • Assessment of cell proliferation (MTT assay) and invasion (Transwell assay).

Main Results:

  • Curcumin significantly inhibited MG-63 cell proliferation and invasion.
  • Curcumin treatment led to increased expression of hsa-miR-138.
  • Overexpression of hsa-miR-138 downregulated Smad4, NFκB p65, and cyclin D3; inhibition of hsa-miR-138 upregulated these targets.

Conclusions:

  • Curcumin enhances hsa-miR-138 expression in osteosarcoma cells.
  • Hsa-miR-138 mediates curcumin's inhibitory effects on cell proliferation and invasion.
  • Targeting Smad4, NFκB p65, and cyclin D3 is a key mechanism for curcumin's anti-osteosarcoma activity.